Combination of pegylated interferon alfa-2b and ribavirin

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Hepatitis C, ChronicInsulin Resistance

Phase 3

Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)

CompletedNCT00265395

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2004-12-31End: 2008-05-31Updated: 2017-04-05

Phase 4

Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)

TerminatedNCT00493805

Merck Sharp & Dohme LLCHepatitis C, Chronic, Insulin Resistance

Start: 2007-04-30End: 2009-10-31Updated: 2017-04-07